Conduit Pharmaceuticals (NASDAQ: CDT) announced the successful completion of Phase I in its AI-driven drug development collaboration with Sarborg Limited. With all milestones achieved, the partnership is now transitioning to Phase II, which will focus on developing personalized software dashboards to improve operational efficiency and decision-making. Phase I, initiated in December 2024, laid the groundwork […]